Stockreport

Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while the successes are well known, investors [Read more]